CO4940405A1 - Formas de dosificacion de solucion encapsulada de sertralina - Google Patents

Formas de dosificacion de solucion encapsulada de sertralina

Info

Publication number
CO4940405A1
CO4940405A1 CO98037136A CO98037136A CO4940405A1 CO 4940405 A1 CO4940405 A1 CO 4940405A1 CO 98037136 A CO98037136 A CO 98037136A CO 98037136 A CO98037136 A CO 98037136A CO 4940405 A1 CO4940405 A1 CO 4940405A1
Authority
CO
Colombia
Prior art keywords
dosage forms
sertralina
encapsulated solution
encapsulated
sertraline
Prior art date
Application number
CO98037136A
Other languages
English (en)
Inventor
William John Curatolo
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4940405(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CO4940405A1 publication Critical patent/CO4940405A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Las formas de dosificación de sertralina encapsuladas en unvehículo inmiscible con agua, que acortan el Tmáx , y/o reducen los efectos secundarios y/o reducen la precipitación de sertralina en medios de uso que contienen ion cloruro, tales como el tracto gastrointestinal.
CO98037136A 1997-07-01 1998-07-01 Formas de dosificacion de solucion encapsulada de sertralina CO4940405A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
CO4940405A1 true CO4940405A1 (es) 2000-07-24

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98037136A CO4940405A1 (es) 1997-07-01 1998-07-01 Formas de dosificacion de solucion encapsulada de sertralina

Country Status (40)

Country Link
EP (1) EP0980241B1 (es)
JP (1) JP3585245B2 (es)
KR (1) KR100371730B1 (es)
CN (1) CN1261792A (es)
AP (1) AP945A (es)
AR (1) AR015916A1 (es)
AT (1) ATE256457T1 (es)
AU (1) AU724635B2 (es)
BG (1) BG103917A (es)
BR (1) BR9809712A (es)
CA (1) CA2290973C (es)
CO (1) CO4940405A1 (es)
DE (1) DE69820608T2 (es)
DK (1) DK0980241T3 (es)
DZ (1) DZ2544A1 (es)
EA (1) EA001905B1 (es)
ES (1) ES2210760T3 (es)
GT (1) GT199800090A (es)
HR (1) HRP980378B1 (es)
HU (1) HUP0002250A3 (es)
ID (1) ID24673A (es)
IL (1) IL133075A0 (es)
IS (1) IS5266A (es)
MA (1) MA24586A1 (es)
MY (1) MY119728A (es)
NO (1) NO996492L (es)
NZ (1) NZ501252A (es)
OA (1) OA11246A (es)
PA (1) PA8454001A1 (es)
PE (1) PE97299A1 (es)
PL (1) PL337807A1 (es)
PT (1) PT980241E (es)
SK (1) SK282914B6 (es)
TN (1) TNSN98123A1 (es)
TR (1) TR199903282T2 (es)
TW (1) TW382597B (es)
UA (1) UA68350C2 (es)
UY (1) UY25070A1 (es)
WO (1) WO1999001113A1 (es)
ZA (1) ZA985709B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
KR100417200B1 (ko) * 1998-10-13 2004-02-05 화이자 프로덕츠 인코포레이티드 세트랄린 경구 농축물
DE122009000036I2 (de) 1999-09-03 2010-05-06 Apbi Holdings Llc Verwendung von Dapoxetin, ein selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Dysfunktion
AU2001276608A1 (en) 2000-08-30 2002-03-13 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
US20040142040A1 (en) * 2002-10-31 2004-07-22 Dong Liang C. Formulation and dosage form providing increased bioavailability of hydrophobic drugs
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2197554A1 (en) * 1994-09-19 1996-03-28 The Du Pont Merck Pharmaceutical Company Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
PT768083E (pt) * 1995-07-17 2003-08-29 Pfizer Sertralina para o tratamento de doentes pos-enfarte miocardico

Also Published As

Publication number Publication date
EP0980241A1 (en) 2000-02-23
CA2290973A1 (en) 1999-01-14
UY25070A1 (es) 2000-12-29
AU7545098A (en) 1999-01-25
AP9801279A0 (en) 1998-06-30
JP3585245B2 (ja) 2004-11-04
GT199800090A (es) 1999-12-21
MY119728A (en) 2005-07-29
MA24586A1 (fr) 1998-12-31
PE97299A1 (es) 1999-10-13
NO996492L (no) 2000-02-29
AU724635B2 (en) 2000-09-28
AR015916A1 (es) 2001-05-30
ZA985709B (en) 2000-01-10
DE69820608D1 (de) 2004-01-29
PA8454001A1 (es) 2000-05-24
IL133075A0 (en) 2001-03-19
JP2000512316A (ja) 2000-09-19
DZ2544A1 (fr) 2003-02-08
ATE256457T1 (de) 2004-01-15
DK0980241T3 (da) 2004-04-05
OA11246A (en) 2002-11-19
TNSN98123A1 (fr) 2005-03-15
ID24673A (id) 2000-07-27
EA199900963A1 (ru) 2000-08-28
CA2290973C (en) 2003-06-17
TW382597B (en) 2000-02-21
BR9809712A (pt) 2000-07-11
EA001905B1 (ru) 2001-10-22
WO1999001113A1 (en) 1999-01-14
PL337807A1 (en) 2000-09-11
HUP0002250A2 (hu) 2000-12-28
ES2210760T3 (es) 2004-07-01
HUP0002250A3 (en) 2001-01-29
PT980241E (pt) 2004-03-31
DE69820608T2 (de) 2004-12-23
SK282914B6 (sk) 2003-01-09
BG103917A (bg) 2000-07-31
KR100371730B1 (ko) 2003-02-07
TR199903282T2 (xx) 2000-08-21
SK180599A3 (en) 2001-01-18
NZ501252A (en) 2004-11-26
CN1261792A (zh) 2000-08-02
HRP980378B1 (en) 2001-12-31
UA68350C2 (en) 2004-08-16
EP0980241B1 (en) 2003-12-17
AP945A (en) 2001-02-28
NO996492D0 (no) 1999-12-27
IS5266A (is) 1999-11-23
KR20010013588A (ko) 2001-02-26
HRP980378A2 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
DE59400068D1 (de) Fällungskieselsäuren
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
BR9501774A (pt) Umidificador e garrafa de água para uso com o mesmo
CO4940405A1 (es) Formas de dosificacion de solucion encapsulada de sertralina
AU2001285942A1 (en) Liquid oligosiloxane containing sulphur and the use thereof in rubber mixtures
DE69931200D1 (de) Lösung mit einem olefinischen Diol und einem pharmazeutischen Wirkstoff
MX9200431A (es) Azapironas:el uso en el desorden de hiperactividad de la falta de atencion.
ECSP982574A (es) Formas de dosificacion de solucion encapsulada de sertralina
DE9213345U1 (de) Flüssiges Körperreinigungsmittel
DE9212733U1 (de) Flüssiges Körperreinigungsmittel
MX9201667A (es) Agentes para el tratamiento de textiles con una capacidad de dispersion en agua mejorada.
ES1033176Y (es) Sistema de aprovechamiento dea aguas ya utilizadas para su uso en el inodoro.
DE69615969T2 (de) Flüssigkeits-Gas-Kontaktkolonne
KR950023279U (ko) 자석체가 내장된 물통
ES1030234Y (es) Receptaculo expositor probatorio, para percibir y probar el olor de cualquier liquido/s que se encuentra/n en su interior, a traves de salida/s tipo roll-on.
ES1025785Y (es) Dispositivo economizador de agua utilizado en cisternas para inodoros.
DE9415022U1 (de) Tablettenartiger Körper mit Bruchkerbe
ES1026268Y (es) Dispositivo para el tratamiento biologico del agua.
ES1024076Y (es) Dispositivo para graduar el volumen de los sujetadores de uso femenino.
ES1038574Y (es) Equipo para filtrar el agua de las piscinas.
KR950006360U (ko) 생수 펌프장치
KR950011898U (ko) 생수펌프장치
ITMC930061A0 (it) Archi capovolti tra due cerchi autorotanti con il terzo con molla
ES1031763Y (es) Dispositivo economizador de agua para cisternas.
ES1022662Y (es) Dispositivo para la utilizacion de bicicletas convencionales como bicicletas estaticas.